A Comparison of Quality-of-Life Domains and Clinical Factors in Ovarian Cancer Patients

A Gynecologic Oncology Group Study

Vivian E. von Gruenigen, Helen Q. Huang, Karen M. Gil, Heidi E. Gibbons, Bradley J. Monk, Peter G. Rose, Deborah Kay Armstrong, David Cella, Lari Wenzel

Research output: Contribution to journalArticle

Abstract

Context: Women diagnosed with ovarian cancer are at risk for reduced quality of life (QOL). It is imperative to further define these declines to interpret treatment outcomes and design appropriate clinical interventions. Objectives: The primary objective of this study was to compare data obtained from ovarian cancer patients with normative data to assess the degree to which QOL differs from the norm. Secondary objectives were to examine demographic variables and determine if there was a correlation between physical/functional and social/emotional scores during chemotherapy. Methods: Patients with Stage III/IV ovarian cancer on Gynecologic Oncology Group Protocols 152 and 172 who underwent surgery followed by intravenous paclitaxel and cisplatin completed the Functional Assessment of Cancer Therapy-Ovarian. The Functional Assessment of Cancer Therapy scale includes the four domains of physical, functional, social, and emotional well-being (PWB, FWB, SWB, and EWB, respectively). Results: Ovarian cancer patients had a total QOL (Functional Assessment of Cancer Therapy-General) score similar to the U.S. female adult population. However, the reported subscale scores were 2.0 points (95% confidence interval [CI] 1.4-2.5, P <0.001, effect size = 0.37) lower in PWB, 0.9 points (95% CI 0.3-1.5, P = 0.005, effect size = 0.13) lower in FWB, 5.0 points (95% CI 4.6-5.3, P <0.001, effect size = 0.74) higher in SWB, and 0.8 points (95% CI 0.3-1.2, P <0.001, effect size = 0.16) lower in EWB. Correlation between the sum of PWB and FWB and the sum of SWB and EWB was r = 0.53 (P <0.001). Age was positively correlated with EWB (r = 0.193; 95% CI 0.09-0.29). Conclusion: Ovarian cancer patients have decreased QOL in physical, functional, and emotional domains; however, they may compensate with increased social support. At the time of diagnosis and treatment, patients' QOL is affected by inherent characteristics. Assessment of treatment outcomes should take into account the effect of these independent variables.

Original languageEnglish (US)
Pages (from-to)839-846
Number of pages8
JournalJournal of Pain and Symptom Management
Volume39
Issue number5
DOIs
StatePublished - May 2010

Fingerprint

Ovarian Neoplasms
Quality of Life
Confidence Intervals
Therapeutics
Social Support
Neoplasms
Demography
Drug Therapy
Population

Keywords

  • chemotherapy
  • Ovarian cancer
  • quality of life

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine
  • Clinical Neurology
  • Nursing(all)

Cite this

A Comparison of Quality-of-Life Domains and Clinical Factors in Ovarian Cancer Patients : A Gynecologic Oncology Group Study. / von Gruenigen, Vivian E.; Huang, Helen Q.; Gil, Karen M.; Gibbons, Heidi E.; Monk, Bradley J.; Rose, Peter G.; Armstrong, Deborah Kay; Cella, David; Wenzel, Lari.

In: Journal of Pain and Symptom Management, Vol. 39, No. 5, 05.2010, p. 839-846.

Research output: Contribution to journalArticle

von Gruenigen, Vivian E. ; Huang, Helen Q. ; Gil, Karen M. ; Gibbons, Heidi E. ; Monk, Bradley J. ; Rose, Peter G. ; Armstrong, Deborah Kay ; Cella, David ; Wenzel, Lari. / A Comparison of Quality-of-Life Domains and Clinical Factors in Ovarian Cancer Patients : A Gynecologic Oncology Group Study. In: Journal of Pain and Symptom Management. 2010 ; Vol. 39, No. 5. pp. 839-846.
@article{b6933cc9fff74cfd93bca6a1af118969,
title = "A Comparison of Quality-of-Life Domains and Clinical Factors in Ovarian Cancer Patients: A Gynecologic Oncology Group Study",
abstract = "Context: Women diagnosed with ovarian cancer are at risk for reduced quality of life (QOL). It is imperative to further define these declines to interpret treatment outcomes and design appropriate clinical interventions. Objectives: The primary objective of this study was to compare data obtained from ovarian cancer patients with normative data to assess the degree to which QOL differs from the norm. Secondary objectives were to examine demographic variables and determine if there was a correlation between physical/functional and social/emotional scores during chemotherapy. Methods: Patients with Stage III/IV ovarian cancer on Gynecologic Oncology Group Protocols 152 and 172 who underwent surgery followed by intravenous paclitaxel and cisplatin completed the Functional Assessment of Cancer Therapy-Ovarian. The Functional Assessment of Cancer Therapy scale includes the four domains of physical, functional, social, and emotional well-being (PWB, FWB, SWB, and EWB, respectively). Results: Ovarian cancer patients had a total QOL (Functional Assessment of Cancer Therapy-General) score similar to the U.S. female adult population. However, the reported subscale scores were 2.0 points (95{\%} confidence interval [CI] 1.4-2.5, P <0.001, effect size = 0.37) lower in PWB, 0.9 points (95{\%} CI 0.3-1.5, P = 0.005, effect size = 0.13) lower in FWB, 5.0 points (95{\%} CI 4.6-5.3, P <0.001, effect size = 0.74) higher in SWB, and 0.8 points (95{\%} CI 0.3-1.2, P <0.001, effect size = 0.16) lower in EWB. Correlation between the sum of PWB and FWB and the sum of SWB and EWB was r = 0.53 (P <0.001). Age was positively correlated with EWB (r = 0.193; 95{\%} CI 0.09-0.29). Conclusion: Ovarian cancer patients have decreased QOL in physical, functional, and emotional domains; however, they may compensate with increased social support. At the time of diagnosis and treatment, patients' QOL is affected by inherent characteristics. Assessment of treatment outcomes should take into account the effect of these independent variables.",
keywords = "chemotherapy, Ovarian cancer, quality of life",
author = "{von Gruenigen}, {Vivian E.} and Huang, {Helen Q.} and Gil, {Karen M.} and Gibbons, {Heidi E.} and Monk, {Bradley J.} and Rose, {Peter G.} and Armstrong, {Deborah Kay} and David Cella and Lari Wenzel",
year = "2010",
month = "5",
doi = "10.1016/j.jpainsymman.2009.09.022",
language = "English (US)",
volume = "39",
pages = "839--846",
journal = "Journal of Pain and Symptom Management",
issn = "0885-3924",
publisher = "Elsevier Inc.",
number = "5",

}

TY - JOUR

T1 - A Comparison of Quality-of-Life Domains and Clinical Factors in Ovarian Cancer Patients

T2 - A Gynecologic Oncology Group Study

AU - von Gruenigen, Vivian E.

AU - Huang, Helen Q.

AU - Gil, Karen M.

AU - Gibbons, Heidi E.

AU - Monk, Bradley J.

AU - Rose, Peter G.

AU - Armstrong, Deborah Kay

AU - Cella, David

AU - Wenzel, Lari

PY - 2010/5

Y1 - 2010/5

N2 - Context: Women diagnosed with ovarian cancer are at risk for reduced quality of life (QOL). It is imperative to further define these declines to interpret treatment outcomes and design appropriate clinical interventions. Objectives: The primary objective of this study was to compare data obtained from ovarian cancer patients with normative data to assess the degree to which QOL differs from the norm. Secondary objectives were to examine demographic variables and determine if there was a correlation between physical/functional and social/emotional scores during chemotherapy. Methods: Patients with Stage III/IV ovarian cancer on Gynecologic Oncology Group Protocols 152 and 172 who underwent surgery followed by intravenous paclitaxel and cisplatin completed the Functional Assessment of Cancer Therapy-Ovarian. The Functional Assessment of Cancer Therapy scale includes the four domains of physical, functional, social, and emotional well-being (PWB, FWB, SWB, and EWB, respectively). Results: Ovarian cancer patients had a total QOL (Functional Assessment of Cancer Therapy-General) score similar to the U.S. female adult population. However, the reported subscale scores were 2.0 points (95% confidence interval [CI] 1.4-2.5, P <0.001, effect size = 0.37) lower in PWB, 0.9 points (95% CI 0.3-1.5, P = 0.005, effect size = 0.13) lower in FWB, 5.0 points (95% CI 4.6-5.3, P <0.001, effect size = 0.74) higher in SWB, and 0.8 points (95% CI 0.3-1.2, P <0.001, effect size = 0.16) lower in EWB. Correlation between the sum of PWB and FWB and the sum of SWB and EWB was r = 0.53 (P <0.001). Age was positively correlated with EWB (r = 0.193; 95% CI 0.09-0.29). Conclusion: Ovarian cancer patients have decreased QOL in physical, functional, and emotional domains; however, they may compensate with increased social support. At the time of diagnosis and treatment, patients' QOL is affected by inherent characteristics. Assessment of treatment outcomes should take into account the effect of these independent variables.

AB - Context: Women diagnosed with ovarian cancer are at risk for reduced quality of life (QOL). It is imperative to further define these declines to interpret treatment outcomes and design appropriate clinical interventions. Objectives: The primary objective of this study was to compare data obtained from ovarian cancer patients with normative data to assess the degree to which QOL differs from the norm. Secondary objectives were to examine demographic variables and determine if there was a correlation between physical/functional and social/emotional scores during chemotherapy. Methods: Patients with Stage III/IV ovarian cancer on Gynecologic Oncology Group Protocols 152 and 172 who underwent surgery followed by intravenous paclitaxel and cisplatin completed the Functional Assessment of Cancer Therapy-Ovarian. The Functional Assessment of Cancer Therapy scale includes the four domains of physical, functional, social, and emotional well-being (PWB, FWB, SWB, and EWB, respectively). Results: Ovarian cancer patients had a total QOL (Functional Assessment of Cancer Therapy-General) score similar to the U.S. female adult population. However, the reported subscale scores were 2.0 points (95% confidence interval [CI] 1.4-2.5, P <0.001, effect size = 0.37) lower in PWB, 0.9 points (95% CI 0.3-1.5, P = 0.005, effect size = 0.13) lower in FWB, 5.0 points (95% CI 4.6-5.3, P <0.001, effect size = 0.74) higher in SWB, and 0.8 points (95% CI 0.3-1.2, P <0.001, effect size = 0.16) lower in EWB. Correlation between the sum of PWB and FWB and the sum of SWB and EWB was r = 0.53 (P <0.001). Age was positively correlated with EWB (r = 0.193; 95% CI 0.09-0.29). Conclusion: Ovarian cancer patients have decreased QOL in physical, functional, and emotional domains; however, they may compensate with increased social support. At the time of diagnosis and treatment, patients' QOL is affected by inherent characteristics. Assessment of treatment outcomes should take into account the effect of these independent variables.

KW - chemotherapy

KW - Ovarian cancer

KW - quality of life

UR - http://www.scopus.com/inward/record.url?scp=77952100387&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77952100387&partnerID=8YFLogxK

U2 - 10.1016/j.jpainsymman.2009.09.022

DO - 10.1016/j.jpainsymman.2009.09.022

M3 - Article

VL - 39

SP - 839

EP - 846

JO - Journal of Pain and Symptom Management

JF - Journal of Pain and Symptom Management

SN - 0885-3924

IS - 5

ER -